Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes

@article{Zanders2015ImpactOC,
  title={Impact of cancer on adherence to glucose-lowering drug treatment in individuals with diabetes},
  author={Marjolein M. J. Zanders and Harm R. Haak and Myrthe P. P. van Herk-Sukel and Lonneke Veronique van de Poll-Franse and Jeffrey A. Johnson},
  journal={Diabetologia},
  year={2015},
  volume={58},
  pages={951-960}
}
Adherence to glucose-lowering drug (GLD) treatment regimens is crucial for metabolic control and improving prognosis. Because a diagnosis of cancer might have an impact on adherence to medication, this study explored changes in adherence to GLDs following a cancer diagnosis. All new users of GLDs between 1998 and 2011 who lived in the Eindhoven Cancer Registry–PHARMO Database Network catchment area were selected. Those with a primary cancer diagnosis during follow-up were considered cases and… CONTINUE READING